China is gaining a solid reputation as a pharmaceutical innovation hub, shifting from a copycat drug maker to one whose…
Read More »Innovent
China’s healthcare sector is on track to secure record fundraising this year, driven by robust global investor demand and growth…
Read More »
When Hong Kong office worker W.K. Chan began putting on weight as a teenager, her doctor said it was due…
Read More »
The global market for diabetes drugs used for treating obesity is expected to expand in Asia, as new players jostle…
Read More »
China has added dozens of new drugs to its health insurance reimbursement list, signalling support for innovative treatments while keeping…
Read More »
An MSCI index tracking 81 Chinese health care stocks with a combined market value of HK$1.15 trillion (US$148 billion) advanced…
Read More »